DPP4 and Alzheimer disease: A recent observation showed that the DPP-4 inhibitor vildagliptin ameliorated neurodegeneration by upregulating BCL-2 and Klotho, and suppressing TNF-α, FOXO1, Bax, and caspase-3 in HFHS diet/AlCl3-induced AD rats [123].